rtsky777

📱Open Assets--Contracts--Today’s Realized Profit and Loss--Funding Fees and Trading Fees-Total Trading Fees📲$BNB .
Like I just played for a month and had nearly 600U in fees, if activated, there’s a 150 oil rebate.
If you filled in the invitation code when registering, then you’re good, that means you have a fee rebate, just find your contact person. If there’s no fee rebate, then this fee is charged by the exchange.
If you wrote my invitation code while playing on Binance, the 100 oil fee can legally refund up to 25 oil to yourself.
Registration invitation code is 1053575781
Contract activation invitation code is 1053951016
If you have to spend, save what you can 👍👍👍

每日一股冷门美股
$FDMT
【个人观点】：后期临床阶段眼科基因治疗 Biotech，核心产品 4D-150 已进入全球三期临床，未来一年半将迎来多个重磅数据催化，属于典型的数据驱动型投资标的，适合关注临床进展博弈，不适合重仓长期持有。
核心数据
股价：13.00 美元，单日上涨 2.44%，盘中最高 13.40 美元，最低 12.63 美元。
总市值：约 6.95 亿美元。
账面现金：截至2025年底，现金、现金等价物及有价证券约5.14亿美元，管理层预计资金可支撑运营至2028年下半年。
30日日均成交额：约1300万美元，流动性一般，属于中小盘Biotech。
做空数据：截至2026年5月中旬，空头持仓约1208万股，做空比例约25%，做空覆盖天数19.1天，若后续临床数据超预期，不排除出现Short Squeeze行情。
我的判断逻辑
公司专注于眼科AAV基因治疗，核心产品4D-150针对湿性年龄相关性黄斑变性（wAMD）及糖尿病黄斑水肿（DME）等大市场疾病，目标是在保持疗效的同时减少患者频繁眼内注射次数，市场空间广阔。
目前4D-150进展持续超预期：
✅ 4FRONT-1全球三期试验已提前完成患者入组；
✅ 4FRONT-2全球三期也已提前约4个月完成入组，显示临床推进顺利；
目前公司现金储备充足，短期融资压力较小，未来股价驱动因素将更多来自临床数据，而不是财务表现。
⚠️潜在风险
Biotech最大的风险仍然来自临床试验。
若PRISM或后续三期数据显示疗效、安全性未达到市场预期，股价可能出现较大波动。
此外，眼科领域竞争激烈，Regeneron、Roche等大型药企均布局相关产品，即使未来获批，也仍需面对市场竞争及商业化执行风险。
未来一年半，公司将持续进入临床数据兑现阶段，每一个关键节点都有可能成为股价的重要催化剂，也是市场关注的核心。
$FDMT.US

35 yuan per day,
so in a week it’s 3500 yuan, and one that has 12000 yuan
Just after graduating from university, to have such a high salary—going to the bank, you’d get $BNB $HOT

A fact you have to acknowledge
A large part of BBA’s desolation is because Huawei Aijie is too outstanding
$BNB

What kind of person is Wei Zhou?

The following information is from Doubao:

Wei Zhou (also known as Zhou Wei) left Binance in June 2021. Officially, it was claimed to be for personal reasons. However, according to information disclosed in Zhao Changpeng (CZ)’s 2026 autobiography *Freedom of Money* and subsequent reports, there were more complex internal conflicts, triggered by specific events.

1. Official statement and basic information
Resignation date: June 9–10, 2021 (reported by multiple media outlets)
Official reason: A Binance spokesperson said, “After Zhou Wei worked at Binance for 3 years, he decided to leave for personal reasons.”
Role background: Zhou Wei was Binance’s first CFO. He joined from Goldman Sachs in September 2018, bringing important institutional credibility to Binance, which had only been established for a year at the time.
Severance package: Binance repurchased his employee stock holdings for $10 million, enabling him to “leave with dignity.”

2. The real reasons: CZ’s autobiography and later reports
Core triggering event: One hour before a 2021 investment decision meeting, investment materials were revised and edited. Zhou Wei deleted key information about an investor, causing CZ to approve the investment while the资料 (materials) were incomplete.
The actual beneficiary of that investment, Rameau, was an old connection Zhou Wei had from his investment-banking days, with a direct private-interest link. If CZ had known, he would likely have vetoed the deal.
In his book, CZ described it as “crossing another line.” The relationship between the two became irreparable, and ultimately led Zhou Wei to resign voluntarily.

The disagreements that existed beforehand: Zhou Wei proposed doing proprietary trading twice, arguing that “we have all the data, so trading is easy,” but both times CZ rejected it.
There was also disagreement over the use of user data. Zhou Wei had suggested using users’ private data, but CZ refused.
Different attitudes toward the FTX investment: Zhou Wei actively pushed Binance to invest in FTX, while CZ initially did not agree.

3. Summary
The official account says Zhou Wei left Binance for personal reasons, but the real reason was a serious rift with CZ regarding investment decisions, corporate strategy, and personal integrity. The relationship ultimately broke after an incident involving the deletion of investment materials and the concealment of related-party interests. He then “left with dignity” through the company’s stock buyback.

Time goes by so fast

My brother went to karaoke with friends. After that, we also went out for dinner.

They didn’t call me for karaoke.

Now my fingers are getting blisters—he’s asking me what happened.
$BNB

Daily One Obscure U.S. Stock:
$ANAB
【Personal View】：A small-cap, game-playing type of Royalty Bio. Suitable for a light position and for an FDA catalyst setup; not recommended for a heavy, long-term hold.
Key Data:
Current price: approx. $65.43 | Total market cap: approx. $1.937 billion
Q1 collaboration revenue: $25.56 million | Cash and investments on the books: $286.5 million
30-day average daily trading volume: approx. $5.12 million | Short interest coverage: about 8 days
My reasoning:
1、The company has completed its business split; the core value has shifted to royalty cash flow. At present, its main revenue comes from GSK Jemperli royalties and the authorized collaboration for Vanda imsidolimab. As Jemperli continues to ramp up, the company’s future cash flows have some upside potential. Meanwhile, it has also launched a $100 million share repurchase program, which should provide some support to the stock price.
2、The key catalyst comes from imsidolimab.
Potential Risks:
① The company still has approximately $264 million in royalty financing liabilities; in the future, part of the Jemperli royalty cash flow will need to be prioritized to repay the Sagard financing arrangement.
② The lawsuits between the company and GSK’s Tesaro over the Jemperli licensing agreement have not yet concluded; subsequent rulings could still affect future royalty revenue.$ANAB.US

This hang-up graphic is clearly fake.
You can tell from the structure of the clothing—there are obvious signs of wearing, but the logo on the clothing shows absolutely no trace at all.
I don’t know why everyone likes looking at pictures so much. It’s all about fantasizing that by becoming A8 or A9 and becoming a big VIP, even if you look like that, you can still attract groups of beautiful women.

AI is too scary now. With just a casual touch-up of an actual photo, it can be made to look indistinguishable from the real thing.
I’m even more convinced by the argument for encryption and the proof of non-fungibility.
Attached are other imagined VIP pictures from other exchanges

Is Xiaomi’s new car so competitive?
You can drive it home for just 500 a month?

They say this is the standard accessory for middle-aged women

Fighting back and forth, and in the end the United States paid reparations

Iran made a sacrifice to get back thirty billion dollars

Men's purchasing power is lower than women's.

Even if you’re just buying a robot,

the male version is 110,000 yen more expensive than the female version.

Do girls go to the gym?
Is it working out for one minute?
Check in for ten minutes
and go home

I know I lost the bet.
I also know that U no longer belongs to me.
But when Binance sends another message reminding me,
it’s like salt being rubbed into my wound—
making me click to see the results. What results? The result of my losing?
🤡

Suddenly gave me a bright youthful feeling

This is too college-student-like

Memory giant Micron discloses its third-quarter results for fiscal year 2026: revenue for the period was US$41.456 billion, up 345.72% year over year; net profit was US$28.243 billion, with a year-over-year increase of 1,398.30%.
The company also made an industry outlook, saying that the global supply shortage of DRAM and NAND flash will continue at least through 2028. $MU.US

Ying Baolin passed away on June 30, 2026, at the age of 82.
He is the actor who played “Meiye” on the show “Chen Xiang Liu Dian Ban”.